Texas judge gives, takes away from Smith & Nephew in Arthrex patent suit

SNN, Arthrex logos

A federal judge in Texas handed Smith & Nephew (NYSE:SNN) a mixed blessing in its ongoing patent infringement fracas with Arthrex Inc., granting an injunction against further infringement but giving Arthrex a stay pending appeal.

The dispute began in 2007, when Smith & Nephew’s Andover, Mass.-based endoscopy division sued Naples, Fla.-based Arthrex in 2007 in the U.S. District Court for Eastern Texas, accusing it of violating a pair of patents covering techniques for attaching anterior cruciate ligament grafts to bone. The companies agreed to dismiss the charges relating to one of the patents, according to court documents, but allowed a jury to decide about the other patent.

That decision went against Arthrex, to the tune of nearly $5 million, after the jury found that its RetroButton femoral fixation device infringed the remaining patent covering Smith & Nephew’s EndoButton fixation device. The jury later added nearly $473,000 in pre-judgment interest, for a total award to Smith & Nephew of nearly $5.2 million, according to court documents.

SNN then sought an injunction preventing Arthrex from selling any more RetroButton products. For its part, Arthrex said at the time that its plans include an appeal and no cessation in RetroButton sales.

Judge T. John Ward granted Smith & Nephew’s motion for an injunction, ruling that the company suffered irreparable harm because the two devices are in direct competition in the market for femoral cortical ACL graft fixation devices.

“Further, Arthrex designed its infringing RetroButton product to compete directly with Smith & Nephew’s EndoButton product and Arthrex has employed marketing and sales tactics to target Smith & Nephew’s customers,” Ward wrote. “Arthrex’s arguments to the contrary, focusing on the adequacy of monetary damages as relief, are not persuasive. Accordingly, the Court finds that Smith & Nephew will suffer irreparable injury absent an injunction.”

But Ward also found that the injunction would irreparably harm Arthrex if it goes into effect before all appeals are exhausted.

“Arthrex argues that customers who leave Arthrex are not likely to switch products yet again once Arthrex prevails on appeal and that the damage to Arthrex’s reputation is likely to be permanent and irreparable. Such loss is not easily measured by money damages and hence qualifies as ‘irreparable harm,'” the judge wrote. “Arthrex has established, and the Court finds, that Arthrex will be irreparably harmed absent a stay.”

The stay doesn’t come without a cost to Arthrex, however. Ward ruled that the company must pay a 36 percent royalty on each RetroButton sale during the duration of the stay. The company must also refrain from making or sponsoring presentations at medical conferences about the RetroButton and EndoButton, eschew comparative advertising and marketing of the products and suspend all sales incentive programs for the RetroButton.

RSS From Medical Design & Outsourcing

  • Emuge expands solid carbide thread mill program with new 3XD sizes
    Emuge is now offering an expanded line of Solid Carbide Thread Mills in their popular THREADS-ALL Program, to include new 3XD sizes designed for maximum reach. A total of 17 new sizes have been added, from miniature to standard size tools, providing maximum versatility in a wide range of thread milling applications. The 3XD THREADS-ALL […]
  • Start of helpful humanoid robots? CITEC uses compact LDS component as sensor array
    Editor’s Note: LaserMicronics, a service provider for laser-based manufacturing, has released the whitepaper “Robot hand with a sensitive touch: LDS tactile sensors for sensorimotor skills.” The paper describes a 2014 project from the CITEC department at Bielefeld University in Bielefeld, Germany, where researchers created a tactile sensor resembling a human fingertip. The sensor was then […]
  • Nature meets technology: Festo’s BionicANTs cooperate to solve a common task
    Editor’s Note: Festo, an industrial control and automation company, has released the whitepaper “BionicANTs: Cooperative behavior based on a natural model.” The paper describes the BionicANT, a creation of Festo engineers that duplicates the physical anatomy of its natural counterpart and reproduces the insect’s cooperative behavior. Festo engineers have used the delicate anatomy of an […]
  • Acorn Regulatory streamlines approval process drug-device manufacturers
    Acorn Regulatory, an ISO-certified medical device and pharmaceutical consulting firm, is streamlining procedures for U.S. manufacturers of drug-device combinations with customized programs that successfully overcome challenges in meeting European regulatory approvals. Focusing on small to mid-size companies, Acorn Regulatory has put in place a comprehensive step-by-step process that provides the correct regulatory pathway for medical […]
  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]

Leave a Reply